PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsEsophageal neoplasms
MeSH D004938 - esophageal neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D005770:Gastrointestinal neoplasms
28 Companies
6 Drugs
$
Success rate
D004935:Esophageal diseases
81 Companies
15 Drugs
$
Success rate
D006258:Head and neck neoplasms
58 Companies
8 Drugs
$
Success rate
D004938: 
Esophageal neoplasms
38 Companies
3 Drugs
$
Success rate
D000077277:Esophageal squamous cell carcinoma
2 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCarboplatin Carboplatin  2005-09-21   
Cisplatin Cisplatin  2000-05-16   
Novast LaboratoriesCarboplatin Carboplatin  2017-04-26   
MylanCarboplatin Carboplatin  2007-04-24   
Cisplatin Cisplatin  2012-04-18   
NATCO PharmaCarboplatin Carboplatin  2012-05-29   
CiplaCarboplatin Carboplatin  2006-01-27   
SandozCarboplatin Carboplatin  2005-03-18   
Sun Pharmaceutical IndustriesCarboplatin Carboplatin  2008-09-19   
HospiraCarboplatin Carboplatin  2004-10-27   
Accord HealthcareCarboplatin Carboplatin  2017-02-09   
Cisplatin Cisplatin  2015-08-18   
Hikma PharmaceuticalsCarboplatin Carboplatin  2004-10-14   
Cisplatin Cisplatin  2000-11-07   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
71%
70/99
Phase 2
24%
36/147
Phase 3
16%
9/58
Approved: 3Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Carboplatin,
Cisplatin
Mylan
Carboplatin
Sandoz
Carboplatin
Accord Healthcare
Cisplatin
Fresenius Kabi
Methotrexate
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use